You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development and Utilization of a Novel Aerosol-Generating Technology to Deliver Luc

    SBC: DISCOVERY LABORATORIES, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Respiratory distress syndrome (RDS) is an acute, severe pulmonary disorder that is the leading cause of morbidity and mortality in preterm infants. It is a major healthcare concern - costs associated with treatment of RDS and its complications exceed 2.4 billion annually in the US. Currently, animal-derived surfactants instilled intratracheally via an endotrac ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

    SBC: DISCOVERY LABORATORIES, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Exposure to ionizing radiation from a nuclear reactor accident or deliberate terrorist actions including the detonation of andquot dirty bombsandquot is a significant public health concern The lung is particularly susceptible to ionizing radiation injury from external sources or inhalation of radioactive particles from radioactive fall out Radiation pneumono ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Engineering of membrane protein chemosensors for therapeutic research

    SBC: INTEGRAL MOLECULAR INC            Topic: NIDCD

    DESCRIPTION provided by applicant Cells require the ability to detect and respond to stimuli in their surroundings including to endogenous metabolites exogenous nutrients and environmental irritants The proteins that are responsible for this process are called chemosensors and are involved in regulating diverse biological processes involved in pain sensation dietary preference and metabol ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Development of P2X3 Ion Channel MAbs for the Treatment of Pain

    SBC: INTEGRAL MOLECULAR INC            Topic: 100

    DESCRIPTION provided by applicant Acute and chronic pain resulting from injury surgery or disease afflicts andgt million Americans each year having a severe impact on mood mental health and quality of life and costing the U S approximately $ billion in economic costs annually For many patients treatment options provide inadequate relief because of the shortcomings of available th ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. A Novel Therapeutic for Invasive Candidiasis

    SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC.            Topic: NIAID

    DESCRIPTION provided by applicant Systemic fungal infections are increasingly common especially in immune compromised patients While new antifungal drugs have been developed there is still a high mortality associated with these infections especially those due to Candida albicans other non albicans species NAS This is due to the limited spectrum of the drugs significant side effects as ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Preclinical testing of the splice modulating oligonucleotide LSP-GR1

    SBC: LifeSplice Pharma            Topic: 106

    DESCRIPTION provided by applicant AMPA glutamate receptors mediate the majority of fast excitatory neurotransmission in the central nervous system Four AMPA receptor subunits exist GluA GluA with functional channels containing various combinations of these four subunits Dysregulation of AMPA receptor expression has been reported in many neurological disorders including amyotrophic latera ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a Small Molecule Inhibitor for EBV Latent Infection

    SBC: VIRONIKA LLC            Topic: NIAID

    DESCRIPTION provided by applicant The goal of this research program is to develop a novel small molecule inhibitor of latent Epstein Barr Virus EBV infection EBV is a ubiquitous gamma herpesvirus that has been classified by the World Health Organization as a human carcinogen Vironika with its consortium partners the Wistar Institute and Fox Chase Chemical Diversity Center Inc will deve ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Novel molecular therapeutics for cystic fibrosis

    SBC: PROGENRA INC            Topic: NHLBI

    DESCRIPTION provided by applicant Cystic fibrosis CF leads to chronic illness disability and early death Recurrent pulmonary infections are lethal owing to growth of bacteria and other microorganisms in the abnormally viscous mucus Antibiotics mucolytics and anti inflammatory agents are useful only in treating some CF effects Recently however ivacaftor a k a VX or Kalydeco w ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Modulators of LDL Metabolism

    SBC: SHIFA BIOMEDICAL CORPORATION            Topic: NHLBI

    DESCRIPTION provided by applicant Heart disease is the leading cause of death for both men and women in the US accounting for nearly of all annual deaths A high cholesterol level is well known risk factors for heart disease Although blood cholesterol can be lowered using a number of marketed drugs of which statins are the leading drugs only of patients taking these drugs are achiev ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Ubiquitin E3 ligase detection by fluorescence resonance transfer

    SBC: PROGENRA INC            Topic: 300

    DESCRIPTION provided by applicant The ubiquitin proteasome pathway degrades of cellular proteins and is of great interest as a source of new therapeutics for multiple diseases The pre proteasomal phase of the pathway catalyzed by the ubiquitin E activating enzyme E conjugating enzyme and E ligase is predicted to afford drugs that act more selectively than proteasome inhibitors ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government